Construction of a transition metal complex directed iodocuprate as the visible light driven photocatalyst

A Co(II) compound: photocatalytic activity and application value in trigeminal neuralgia with minimally invasive interventional therapy guided by CT

A new thermostable Co(II)-based compound, namely [Co₃(L)₂(HTEA)₂]_n (1, HL = isonicotinic acid, H₃TEA = triethanolamine), has been successfully synthesized by the isomicotinic acid ligand and HTEA anion. The photocatalytic property of 1 was also investigated, indicating that it shows excellent photocatalytic activity for the degradation of Rhodamine B (MB) solution under the UV light irradiation. For the treatment of trigeminal neuralgia, the content of the inflammatory cytokines released into the trigeminal ganglion tissue fluid was measured with enzyme-linked immunosorbent assay (ELISA) assay. Then, the real-time Reverse Transcription-Polymerase Chain Reaction (RT-PCR) was conducted and the activation of the nuclear factor kappa-B (NF-κB) inflammatory signaling pathway was measured.

Construction of a New 3D Cu(II) Compound with Photocatalytic Activity and Therapeutic Effect on Ventriculitis

A new Cu(II) compound, that is {[Cu(L)(ClO4)(H2O)(CH3CN)](ClO4)}n (1, L is 4-(furan-2-yl)-2,6-bis(pyridin-2-yl)pyridine), was solvothermally synthesized and structurally characterized. It features a 0D isolated unit, and these 0D isolated units are further hydrogen-bonded into a 3D supramolecular framework. The framework of 1 can be stable up to 284°C, and the optical band gap of 1 is 3.71 eV. Under the irradiation of ultraviolet light, complex 1 as a photocatalyst exhibits high activity for methylene blue (MB) degradation in the water solution. The above compound’s inhibitory activity on the inflammatory cytokines releasing was tested through exploiting ELISA detection. The real time RT-PCR was conducted to assess the compound’s suppression on the expression of bacterial survival gene.